about
Acute hemodynamic effects of octreotide and terlipressin in patients with cirrhosis: a randomized comparison.Acute esophageal variceal bleeding: Current strategies and new perspectivesRevision and update on clinical practice guideline for liver cirrhosis.Variceal bleeding: pharmacological therapy.Portal hypertension and gastrointestinal bleeding: diagnosis, prevention and management.Vapreotide acetate for the treatment of esophageal variceal bleeding.Vapreotide: a somatostatin analog for the treatment of acute variceal bleeding.Nonendoscopic management strategies for acute esophagogastric variceal bleeding.Efficacy of vasopressin/terlipressin and somatostatin/octreotide for the prevention of early variceal rebleeding after the initial control of bleeding: a systematic review and meta-analysis.Gastrointestinal Bleeding in Cirrhotic Patients with Portal Hypertension.Prevention and treatment of variceal haemorrhage in 2017.The somatostatin analogue octreotide inhibits angiogenesis in the earliest, but not in advanced, stages of portal hypertension in rats.Use of portal pressure studies in the management of variceal haemorrhage.Hemodynamic effects of terlipressin and high somatostatin dose during acute variceal bleeding in nonresponders to the usual somatostatin dose.Immediate effects of different schedules of somatostatin on portal pressure in patients with liver cirrhosis.Randomised clinical trial: the safety and efficacy of long-acting octreotide in patients with portal hypertension.
P2860
Q34555615-AD16993E-064C-481D-BF8E-3F01420BC6BEQ34625821-B30A3095-CE7B-47A0-8276-4BB352D4A237Q35890613-34FD79F5-0848-4D63-9934-14B3415E5A33Q36141427-0E0C82A6-B0EA-4AF8-A35F-146B00AB2F32Q37102443-2745B885-F651-4E04-82F7-EA3112F51A6EQ37345862-0B4A4B7A-FEB6-41AA-9280-C3786F9E254DQ37587233-4CB4ECBC-2AA2-4756-B49C-8C6562F23939Q38273947-4E0A8B61-E569-4372-9422-DF475F99385BQ38383505-A8C523E9-74B2-4570-A834-6E8ABB1ADA72Q38874220-E13E97C5-0544-469F-A561-52C6C84BB548Q39067320-18F01E5F-5AB1-4366-BB7E-4BE9C575FE5DQ41933915-7E67217B-BB33-4F2B-BD34-E7A288099A96Q42240290-0208447B-ECD9-4FD1-B09C-4DF0AF3DB0C8Q45294730-BEB5A507-882F-4BBA-88BC-30C76E5DE83CQ46498520-D95390C7-FCC1-4A5D-B942-13FCC965621EQ51360310-2D5A8797-E4EA-4529-8AB8-90A826F871A9
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Somatostatin and analogues in portal hypertension.
@ast
Somatostatin and analogues in portal hypertension.
@en
Somatostatin and analogues in portal hypertension.
@nl
type
label
Somatostatin and analogues in portal hypertension.
@ast
Somatostatin and analogues in portal hypertension.
@en
Somatostatin and analogues in portal hypertension.
@nl
prefLabel
Somatostatin and analogues in portal hypertension.
@ast
Somatostatin and analogues in portal hypertension.
@en
Somatostatin and analogues in portal hypertension.
@nl
P356
P1433
P1476
Somatostatin and analogues in portal hypertension
@en
P2093
Jaime Bosch
P304
P356
10.1053/JHEP.2002.33469
P407
P577
2002-06-01T00:00:00Z